NasdaqGS - Nasdaq Real Time Price USD
Prelude Therapeutics Incorporated (PRLD)
0.8688
-0.0144
(-1.63%)
As of 9:46:51 AM EDT. Market Open.
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 0 | 0 |
| Sales | -- | 0 |
| Net Shares Purchased (Sold) | 0 | 0 |
| Total Insider Shares Held | 6.28M | -- |
| % Net Shares Purchased (Sold) | -- | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| HUANG JANE President | -- | Direct | -- | Apr 4, 2025 |
| VADDI KRISHNA Chief Executive Officer | Purchase at price 0.69 per share. | Direct | 467,438 | Mar 25, 2025 |
| COMBS ANDREW P Officer | Purchase at price 0.69 per share. | Direct | 69,250 | Mar 25, 2025 |
| VADDI KRISHNA Chief Executive Officer | Purchase at price 0.73 per share. | Direct | 14,909 | Mar 21, 2025 |
| VADDI KRISHNA Chief Executive Officer | Purchase at price 0.75 per share. | Direct | 29,460 | Mar 17, 2025 |
| VADDI KRISHNA Chief Executive Officer | Purchase at price 0.71 - 0.72 per share. | Direct | 69,564 | Mar 13, 2025 |
| HUANG JANE President | -- | Direct | -- | Jan 3, 2025 |
| VADDI KRISHNA Chief Executive Officer | Purchase at price 1.21 per share. | Indirect | 6,044 | Dec 31, 2024 |
| VADDI KRISHNA Chief Executive Officer | Purchase at price 1.20 per share. | Indirect | 12,000 | Dec 30, 2024 |
| COMBS ANDREW P Officer | Purchase at price 1.15 - 1.37 per share. | Direct | 85,538 | Dec 23, 2024 |
| LIM BRYANT DAVID Chief Financial Officer | Purchase at price 0.91 per share. | Direct | 22,638 | Dec 19, 2024 |
| VADDI KRISHNA Chief Executive Officer | Purchase at price 0.89 - 0.93 per share. | Indirect | 99,326 | Dec 19, 2024 |
| HUANG JANE President | -- | Direct | -- | Oct 4, 2024 |
| HUANG JANE Officer | -- | Direct | -- | Jul 3, 2024 |
| HUANG JANE President | -- | Direct | -- | Apr 4, 2024 |
| HUANG JANE President | -- | Direct | -- | Jan 4, 2024 |
| HUANG JANE President | -- | Direct | -- | Oct 4, 2023 |
| HUANG JANE President | -- | Direct | -- | Jul 4, 2023 |
| VADDI KRISHNA Chief Executive Officer | Purchase at price 5.01 - 5.31 per share. | Direct | 9,790 | May 25, 2023 |
| LIM BRYANT DAVID Officer | Purchase at price 5.39 per share. | Direct | 12,936 | May 24, 2023 |
| CHARDONNET LAURENT Chief Financial Officer | Purchase at price 5.50 per share. | Direct | 27,500 | May 23, 2023 |
| VADDI KRISHNA Chief Executive Officer | Purchase at price 5.63 per share. | Direct | 66,749 | May 23, 2023 |
| BONITA DAVID P. M.D. Director and Beneficial Owner of more than 10% of a Class of Security | Purchase at price 5.75 per share. | Indirect | 4,999,999 | May 22, 2023 |
| ORBIMED ADVISORS, L.L.C. Beneficial Owner of more than 10% of a Class of Security | Purchase at price 5.75 per share. | Indirect | 4,999,999 | May 22, 2023 |
Related Tickers
STTK Shattuck Labs, Inc.
0.8513
0.00%
FHTX Foghorn Therapeutics Inc.
4.5800
-2.14%
TCRX TScan Therapeutics, Inc.
1.6600
+1.84%
PMVP PMV Pharmaceuticals, Inc.
1.0600
-0.93%
INCY Incyte Corporation
57.78
-0.39%
KYMR Kymera Therapeutics, Inc.
31.70
+3.26%
NRIX Nurix Therapeutics, Inc.
11.55
-0.52%
PASG Passage Bio, Inc.
0.3176
-5.48%
PEPG PepGen Inc.
1.6219
+0.74%
CCCC C4 Therapeutics, Inc.
1.6000
-0.62%